Drug interaction between sevelamer and furosemide

被引:8
作者
Fleuren, HWHA
Kho, Y
Schuurmans, MMJ
Vollaard, EJ
机构
[1] Canisius Wilhelmina Hosp, Dept Clin Pharm, NL-6500 GS Nijmegen, Netherlands
[2] Canisius Wilhelmina Hosp, Dept Nephrol, NL-6500 GS Nijmegen, Netherlands
关键词
appetite; end-stage renal disease; ghrelin; left ventricular function;
D O I
10.1093/ndt/gfi020
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
引用
收藏
页码:2288 / 2289
页数:3
相关论文
共 7 条
[1]   A comparison of the calcium-free phosphate binder sevelamer hydrochloride with calcium acetate in the treatment of hyperphosphatemia in hemodialysis patients [J].
Bleyer, AJ ;
Burke, SK ;
Dillon, M ;
Garrett, B ;
Kant, KS ;
Lynch, D ;
Rahman, SN ;
Schoenfeld, P ;
Teitelbaum, I ;
Zeig, S ;
Slatopolsky, E .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1999, 33 (04) :694-701
[2]   Bile acid binding to sevelamer HCl [J].
Braunlin, W ;
Zhorov, E ;
Guo, A ;
Apruzzese, W ;
Xu, QW ;
Hook, P ;
Smisek, DL ;
Mandeville, WH ;
Holmes-Farley, SR .
KIDNEY INTERNATIONAL, 2002, 62 (02) :611-619
[3]   Sevelamer hydrochloride (Renagel®), a nonabsorbed phosphate-binding polymer, does not interfere with digoxin or warfarin pharmacokinetics [J].
Burke, S ;
Amin, N ;
Incerti, C ;
Plone, M ;
Watson, N .
JOURNAL OF CLINICAL PHARMACOLOGY, 2001, 41 (02) :193-198
[4]   Sevelamer hydrochloride (Renagel®), a phosphate-binding polymer, does not alter the pharmacokinetics of two commonly used antihypertensives in healthy volunteers [J].
Burke, SK ;
Amin, NS ;
Incerti, C ;
Plone, MA ;
Lee, JW .
JOURNAL OF CLINICAL PHARMACOLOGY, 2001, 41 (02) :199-205
[5]  
GUILLENANAYA MA, 2004, NEPHROL DIAL TRANSLP, V19, P1939
[6]   Effects of sevelamer hydrochloride and calcium acetate on the oral bioavailability of ciprofloxacin [J].
Kays, MB ;
Overholser, BR ;
Mueller, BA ;
Moe, SM ;
Sowinski, KM .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2003, 42 (06) :1253-1259
[7]  
Moffat A.C., 1986, CLARKES ISOLATION ID